Afghanistan vs Azerbaijan: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Azerbaijan
100.0%
in 2024
Afghanistan rank
1st
Azerbaijan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Azerbaijan
How they compare
Afghanistan currently reports 100.0% against 100.0% in Azerbaijan, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2011 it was Afghanistan ahead.
Afghanistan ranks 1st and Azerbaijan ranks 1st of 144 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Azerbaijan in 1.
Head to head by decade
| Decade | Afghanistan | Azerbaijan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 75.7% | 76.6% | 0.9% | Azerbaijan |
| 2020s | 100.0% | 98.2% | 1.8% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Azerbaijan?
- Afghanistan, at 100.0% against 100.0% in Azerbaijan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Azerbaijan?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Azerbaijan?
- 12 years are reported by both, from 2011 to 2024.
- How do Afghanistan and Azerbaijan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Azerbaijan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.